In our study, we report a significant increase in MBP levels following Aβ treatment in cultured OLs, in the hippocampus of early-stage 3xTg AD mice, and in human hippocampal lysates from individuals with high Aβ levels. The gene discussed is MBP; the disease is Alzheimer disease.